These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2765189)

  • 1. Roles of neurotransmitter receptors in behavior: recovery of function following decreases in muscarinic receptor density induced by cholinesterase inhibition.
    Russell RW; Booth RA; Smith CA; Jenden DJ; Roch M; Rice KM; Lauretz SD
    Behav Neurosci; 1989 Aug; 103(4):881-92. PubMed ID: 2765189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic receptor binding and behavioral effects of atropoine following chronic catecholamine depletion or acetylcholinesterase inhibition in rats.
    Schallert T; Overstreet DH; Yamamura HI
    Pharmacol Biochem Behav; 1980 Aug; 13(2):187-92. PubMed ID: 7413689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and neurochemical changes in rats dosed repeatedly with diisopropylfluorophosphate.
    Bushnell PJ; Padilla SS; Ward T; Pope CN; Olszyk VB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):741-50. PubMed ID: 1994004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of muscarinic and nicotinic receptors in behavioral tolerance to DFP.
    Overstreet DH; Russell RW; Vasquez BJ; Dalglish FW
    Pharmacol Biochem Behav; 1974; 2(1):45-54. PubMed ID: 4828482
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation of muscarinic receptor density and acetylcholinesterase activity in repeated DFP-treated rats after the termination of DFP administration.
    Lim DK; Hoskins B; Ho IK
    Eur J Pharmacol; 1986 Apr; 123(2):223-8. PubMed ID: 3709665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic, low-level exposure to diisopropylfluorophosphate causes protracted impairment of spatial navigation learning.
    Prendergast MA; Terry AV; Buccafusco JJ
    Psychopharmacology (Berl); 1997 Jan; 129(2):183-91. PubMed ID: 9040125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and neurochemical effects of acute chlorpyrifos in rats: tolerance to prolonged inhibition of cholinesterase.
    Bushnell PJ; Pope CN; Padilla S
    J Pharmacol Exp Ther; 1993 Aug; 266(2):1007-17. PubMed ID: 7689099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic neuropharmacology: an update.
    Palacios JM; Boddeke HW; Pombo-Villar E
    Acta Psychiatr Scand Suppl; 1991; 366():27-33. PubMed ID: 1654727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated inhibition of cholinesterase by chlorpyrifos in rats: behavioral, neurochemical and pharmacological indices of tolerance.
    Bushnell PJ; Kelly KL; Ward TR
    J Pharmacol Exp Ther; 1994 Jul; 270(1):15-25. PubMed ID: 7518512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral and physiological effects associated with changes in muscarinic receptors following administration of an irreversible cholinergic agonist (BM 123).
    Russell RW; Smith CA; Booth RA; Jenden DJ; Waite JJ
    Psychopharmacology (Berl); 1986; 90(3):308-15. PubMed ID: 3097716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of muscarinic cholinoceptors of guinea pig brain and ileum to chronic administration of carbamate or organophosphate cholinesterase inhibitors.
    Dawson RM; Jarrott B
    Biochem Pharmacol; 1981 Aug; 30(16):2365-8. PubMed ID: 7295348
    [No Abstract]   [Full Text] [Related]  

  • 12. Muscarinic cholinergic receptor regulation and acetylcholinesterase inhibition in response to insecticide exposure during development.
    Dvergsten C; Meeker RB
    Int J Dev Neurosci; 1994 Feb; 12(1):63-75. PubMed ID: 8010161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flinders resistant hypocholinergic rats exhibit startle sensitization and reduced startle thresholds.
    Markou A; Matthews K; Overstreet DH; Koob GF; Geyer MA
    Biol Psychiatry; 1994 Nov; 36(10):680-8. PubMed ID: 7880937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of oral chlorpyrifos effects on behavior, cholinesterase inhibition, and muscarinic receptor density in rat.
    Nostrandt AC; Padilla S; Moser VC
    Pharmacol Biochem Behav; 1997 Sep; 58(1):15-23. PubMed ID: 9264064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in brain muscarinic acetylcholine receptors and behavioral responses to atropine and apomorphine in chronic atropine-treated rats.
    Takeyasu K; Uchida S; Noguchi Y; Fujita N; Saito K; Hata F; Yoshida H
    Life Sci; 1979 Aug; 25(7):585-92. PubMed ID: 502751
    [No Abstract]   [Full Text] [Related]  

  • 16. Exposure to an organophosphate (DFP) during a defined period in neonatal life induces permanent changes in brain muscarinic receptors and behaviour in adult mice.
    Ahlbom J; Fredriksson A; Eriksson P
    Brain Res; 1995 Apr; 677(1):13-9. PubMed ID: 7606457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of dopamine in behavioral supersensitivity to muscarinic antagonists following cholinesterase inhibition.
    Fernando JC; Hoskins B; Ho IK
    Life Sci; 1986 Dec; 39(23):2169-76. PubMed ID: 3784773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of chronic lithium pretreatment on rat brain muscarinic receptor regulation.
    Levy A; Zohar J; Belmaker RH
    Neuropharmacology; 1982 Nov; 21(11):1199-201. PubMed ID: 7177345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation and blockade of cardiac muscarinic receptors by endogenous acetylcholine and cholinesterase inhibitors.
    Brown JH; Wetzel GT; Dunlap J
    J Pharmacol Exp Ther; 1982 Oct; 223(1):20-4. PubMed ID: 6288918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the role of brain cholinergic systems in the therapeutic mechanisms and adverse effects of ECT and lithium.
    Lerer B
    Biol Psychiatry; 1985 Jan; 20(1):20-40. PubMed ID: 3917309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.